Tempus partners with Whitehawk Therapeutics for cancer research
Go back to Tempus partners with Whitehawk Therapeutics for cancer research| StemCells, Inc. (NASDAQ: TEM) | Delayed: 54.61 -1.08 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.69 | 52 Week High | $0.45 | |||
| Open | $56.00 | 52 Week Low | $0.37 | |||
| Day High | $57.03 | P/E | N/A | |||
| Day Low | $53.73 | EPS | $-0.31 | |||
| Volume | 4,387,658 | |||||
| (NASDAQ: WHWK) | Delayed: 4.71 +0.04 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.67 | 52 Week High | $ | |||
| Open | $4.65 | 52 Week Low | $ | |||
| Day High | $4.79 | P/E | N/A | |||
| Day Low | $4.50 | EPS | $ | |||
| Volume | 310,893 | |||||

